氨己烯酸医保给予报销吗？

The prevalence of epilepsy is 0.5%, 0.72% and 1.12% in developed, developing and underdeveloped countries respectively. The global average incidence of epilepsy is about 0.6%, one-third of which are refractory. General treatment methods include a combination of drugs, surgery, ketogenic diet, vagus nerve stimulation and other treatments. The common name of Vigabatrin is vigabatrin. Vigabatrin is a drug used to treat epilepsy and infantile spasms. It was developed in the 1980s. The treatment was approved in the UK in 1989. On August 21, 2009, the US FDA approved vigabatrin as monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjunctive (additional) treatment for adult patients with refractory complex partial epilepsy (CPS).

Vigabatrin tablets are an oral drug that is rapidly absorbed after oral administration and can reach its peak blood level 2 hours after taking it. The maximum daily dosage for adults is 2-3g. It is appropriate to start with 1g a day. Then, depending on the response after taking the medication, if the response is good, it can be increased by 0.5g every week, and finally reaches a dosage of 2-3g per day. The recommended dosage for children is 40 mg/kg/day. Continuous medication should be judged based on the patient's weight. The recommended dosage for children weighing 10-15kg is 0.5-1g/day; the recommended dosage for 15-30kg is 1-1.5g/day; the recommended dosage for 30-50kg is 1.5-3g/day; >50kg 2-3g/day.

Vigabatrin tablets are oral medicines that can be taken once or twice a day, before or after meals. It is advisable to drink half a glass of water when taking this medicine for treatment. If you have taken this drug for a sufficient period of time and your epilepsy still does not improve, you should stop taking Vigabatrin. At this time, vigabatrin tablets (Vigabatrin) should be gradually stopped under the supervision of a doctor. The use of vigabatrin tablets and vigabatrin should be done under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

Will vigabatrin be reimbursed by medical insurance?

Vigabatrin is not marketed in China, nor is it included in the medical insurance catalog. It is understood that Vigadrone is only available in a few countries, and Vigadrone produced by Sanofi in France is cost-effective. Its specifications are 500 mg

The above is the introduction about it, I hope it can help you.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: